Avalo Therapeutics
AVTX
AVTX
28 hedge funds and large institutions have $159K invested in Avalo Therapeutics in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 7 closing their positions.
Holders
28
Holders Change
+2
Holders Change %
+7.69%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
5
Reduced
6
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
NFSG
26
Newbridge Financial Services Group
Boca Raton,
Florida
| $1 | 10 | – | – |
|
|
VA
27
VR Adviser
New York
| – | – | -1,250,000 | Closed |
|
|
NCM
28
Nantahala Capital Management
New Canaan,
Connecticut
| – | – | -556,202 | Closed |
|
29
Millennium Management
New York
| – | – | -33,933 | Closed |
|
|
HF
30
HRT Financial
New York
| – | – | -13,106 | Closed |
|
31
JPMorgan Chase & Co
New York
| – | – | -12,993 | Closed |
|
32
Commonwealth Equity Services
Waltham,
Massachusetts
| – | – | -10,762 | Closed |
|
33
Bank of America
Charlotte,
North Carolina
| – | – | -4,127 | Closed |
|
34
Royal Bank of Canada
Toronto,
Ontario, Canada
| $0 | 471 | -1,047 | -69% |
|
|
CFGS
35
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
PA
36
Parallel Advisors
San Francisco,
California
| $0 | 1 | – | – |
|